Look at the top 5 cards of either player's deck and put them back on top of that player's deck in any order.
Flip a coin. If heads, the Defending Pokémon is now Paralyzed.
Release year for HS—Triumphant is 2010. Series classification for this set is HeartGold & SoulSilver.
The checklist contains 103 cards, placing it in a mid-size expansion range. As of 2026, the set is 16 years old and fits a legacy-era profile.
Within this set, Celebi is card number 3 with a Rare Holo designation.
Celebi is a HS—Triumphant card from the 2010 release window. The printed flavor text states: "This Pokémon wanders across time.
Grass and trees flourish in the forests in which it has appeared." Its card type is Pokémon. The rarity label is Rare Holo.
Printed HP is 70. Energy typing is Psychic.
This gives collectors a clear identity footprint for the print. Card subtype classification is Basic.
Latest market snapshots place Celebi in HS—Triumphant at roughly $10.65. Week-over-week change is limited (0.0%), indicating short-term stability.
Current value is elevated versus the 30-day mean ($9.10), by 17.1%. Its 90-day trading band runs between $6.68 and $10.65, producing a 37% range and moderate-volatility behavior.
This version is categorized as Rare Holo.
Collectors tracking Celebi often benchmark it against other Celebi cards. Comparable entries in this snapshot: 6 cards, 4 distinct sets.
Observed alternatives run from $0.09 to $36.44 (40389% spread). The current card sits +2% versus the sampled alternative average of $10.39.
Notable alternatives include Celebi #XY187 (XY Black Star Promos) at $7.90, Celebi #XY93 (XY Black Star Promos) at $13.03, Celebi #XY111 (XY Black Star Promos) at $36.44, and Celebi #3 (Shining Fates) at $0.23.
Market structure summary: The latest week is near flat (0.0%), suggesting consolidation rather than breakout behavior. Observed 90-day bounds of $6.68 and $10.65 create a 37% band, matching a moderate-volatility profile.
Current value is 17.1% above its 30-day reference ($9.10). Graded context points to a substantial premium curve, with PSA 10 at +11938% above raw pricing.
PSA 9 is currently around $41.00, while PSA 10 is $1282.05.
